Pedro Canas da Silva

Showing 1-2 of 2 articles

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabaté M

April 20, 2018 | 10.4244/EIJ-D-17-00462

Coronary interventions

Portugal: coronary and structural heart interventions from 2010 to 2015

Teles R, Pires Morais G, da Silva P, Ferreira R, de Sousa Almeida M, Seixo F, Costa M, Ribeiro V, Marques J, Silva J, Pereira H, e Abreu P, Carvalho H, de Oliveira E

May 15, 2017 | 10.4244/EIJ-D-16-00831

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Introducing the new Editorial Board

This week's JAA's: Right pulmonary artery to left atrium fistula, BRS in high-risk patients

This week’s JAA’s: VIV-TAVR outcomes, Failing homograft AVR: 5 year outcomes...

Predicting the Future for LM Revascularization? Choosing the Right Fortune Teller…

Philippe Généreux

Guidance Papers

Guidelines, consensus & position papers

Radiofrequency renal denervation is effective - and safe?

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke